Business News • PR NewsWire • OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics

OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics

OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics

REDWOOD CITY, Calif., June 17 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc. and Bayer Schering Pharma AG, Germany, today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway. Cancer stem cells

View More : http://www.prnewswire.com/news-releases/oncomed-pharmaceuticals-and-bayer-schering-pharma-announce-strategic-alliance-to...

Releted News by prnewswire

Cognizant Acquires Paris-Based Galileo Performance, an Information Technology Testing Consultancy

Analysis of the Current Situation and Prospects in the Chinese CWSF Market

Truphone(TM) Announces Agreements With Vodafone Netherlands and Orange in Spain

ASE Files 2009 Annual Report on Form 20-F